Blood cancers, Non-Hodgkin lymphoma (NHL)
Open
Phase 1/2
This trial is looking at a new drug called MK‑1045 for follicular lymphoma and diffuse large B cell lymphoma.
It is for people whose lymphoma has:
come back after treatment or
continued to grow despite treatment
Recruitment start: 26 May 2026
Recruitment end: 3 June 2028
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Elizabeth Phillips
Merck Sharp & Dohme LLC
Last reviewed: 08 Sept 2026
CRUK internal database number: 20183
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
